Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Peptides. 2010 Oct 20;32(1):51–59. doi: 10.1016/j.peptides.2010.10.017

Fig. 3.

Fig. 3

Blockade of intraperitoneal Ucn 1 and Ucn 2 anorexigenic effect by the CRF2 antagonist, astressin2-B, after intraperitoneal (A) but not intracerebroventricular administration (B) in overnight fasted mice. Astressin2-B did not have effect on a peripheral non CRF receptor-binding peptide, CCK-8S–inhibited food intake (A). Data are mean ± SEM. Animals per group are indicated on each bar. * p < 0.05, vs. vehicle + vehicle. # p < 0.05 vs. vehicle + Ucn 1 or Ucn 2.